What We Do
LifeDose is a non-profit pharmaceutical company developing a reliable and affordable supply of life-saving medication naloxone, to reduce the growing number of overdose deaths in the U.S.
LifeDose envisions a world where people no longer die from accidental overdoses—where everyone has access to the information and medication they need to save lives.
Opioid overdose is a leading cause of accidental death in the United States. In the U.S., we lose 63 people every day to an overdose of prescription painkillers or heroin—and the death rate is rising.
But there is a network of community based organizations (CBOs) already equipped to respond to this crisis. Coming out of the AIDS activism movement, syringe exchange programs and other CBOs have for years taught people who use drugs how to respond to and prevent overdoses. These CBOs distribute naloxone, a medication that instantaneously reverses the effects of an opioid overdose.
In 2014, 136 CBOs distributed naloxone via 644 sites—and the number of programs has grown exponentially since then. From 1996-2014, CBOs trained 152,283 community members—mostly drug users—who intervened a reported 26,463 times.
Each of these instances represents a potential life saved by another community member.
Yet the need for naloxone is greater than ever. Because of skyrocketing opioid use, along with broader public awareness regarding the efficacy of CBOs' distribution networks, there are now many new customers for naloxone. In addition, the market size is expanding as the Dept. of Veteran Affairs, emergency first responders, local health departments, parent groups, drug treatment programs and others all seek sources for affordable naloxone.